Teoxane Laboratories

Teoxane Laboratories Overview

Company Headquarters: Geneva, Switzerland

Founded: 2003

Workforce: ~500

Company Working: Teoxane Laboratories (Teoxane) is specialized in the designing and manufacturing of hyaluronic acid (HA)-based dermal fillers and cosmeceuticals. The company offers skin treatment products that are used for reducing wrinkles, restoring youthful volume to the face, and treating the neck and décolleté with-looking natural results. It focuses on medical devices, aesthetic products, skin care, beauty, anti-aging solutions, dermal fillers, and dermis redensification. The company has a strong distribution network in more than 95 countries as well as more than 10 subsidiaries in France, UK, Italy, Spain, Germany, Switzerland, Poland, Australia, Russia, Dubai, and Singapore.

Strategy

Teoxane focuses on developing innovative technologies to deliver best-in-class solutions. It also aims at providing quality products and services to maintain a diversified business with a strong pipeline of new products. The company has been taking steps to expand its sales in emerging markets such as India and China. Teoxane also focuses on maintaining and enhancing customer satisfaction by providing quality products and improving customer support and services.

Company Snapshot

500

Employees

2003

Founded

Geneva, Switzerland

Headquarters

SWOT Analysis

Strengths

Recognized brand
Strong global presence
Provides high-quality and cost-effective products
Strong pipeline of dermal filler products

Weaknesses

Limited workforce

Opportunities

Investing in R&D
Customer engagement through online channels
Product innovation and rising research and development activity

Threats

Increasing rivalry in the market
Rapid technological developments
Increasing raw material costs

Key Developments

Date	Approach	Development
January 2020	Agreement	Teoxane announced an exclusive distribution agreement with Revance Therapeutics (US). This agreement provides Revance Therapeutics the right to commercialize Teoxane’s RHA line of fillers in the US, starting with its FDA-approved RHA 2, RHA 3, and RHA 4 products, as well as Teoxane’s RHA 1 dermal filler, which is currently undergoing clinical trials. This agreement provides support for the expansion of the company’s dermal fillers business in the US.

Product Offering

Teoxane Laboratories
- Dermal Fillers

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.